Flanders 1 included a 61,000 SF cGMP manufacturing suites for both Clean Cap Technology and mRNA including validated SDS, RODI, WIFI, and heat sanitization systems. Spaces also included R&D, QC lab spaces as well as warehousing and complete new central plants.
Flanders 2 is a 31,000 SF mRNA Manufacturing Facility. TI includes cGMP mRNA manufacturing suites, buffer lab, QC/micro lab space, RODI, heat sanitization and WiFi systems. Includes new central plant and 1MW generator. Constructed for FDA Certification at a future time.
Please include your contact information and any related documents below to apply for the position below.
